$10B Offer from Pfizer Outshines Novo Nordisk for Metsera
The CEO of Novo Nordisk issued a bold challenge to Pfizer, urging […]
$6.5B Bid by Novo Nordisk to Outmaneuver Pfizer in Obesity Deal
In September, the competition for acquiring the metabolic medicines biotech company Metsera […]
Metabolic Drug Strategy: Roche Acquires 89bio for $2.4B
Roche has made a significant move in the pharmaceutical landscape by agreeing […]
Tourmaline Acquisition: Novartis’s $1.4B Heart Drug Potential
The management of cardiovascular disease often involves a range of medications, but […]
$10B Deal Boosts Merck’s Respiratory Prospects with Verona Pharma
Merck has finalized a significant $10 billion acquisition of Verona Pharma, a […]
Brain Cancer Drug Leads to $935M Jazz Pharma Acquisition
Exploring Innovative Treatments for Brain Cancer: Jazz Pharmaceuticals’ $935 Million Commitment Brain […]